Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

@article{Capuron2000EarlyDS,
  title={Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.},
  author={Lucile Capuron and Alain Mure Ravaud and Robert Dantzer},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2000},
  volume={18 10},
  pages={2143-51}
}
PURPOSE Depressive symptomatology is frequently associated with interleukin (IL)-2 and interferon alfa-2b (INFalpha-2b) therapy in cancer patients. The objective of the present study was to evaluate the depressive and anxiety symptoms induced by IL-2 and/or INFalpha-2b in cancer patients during the first days of cytokine immunotherapy. PATIENTS AND… CONTINUE READING